Anaplastic astrocytoma

Search Trials
PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas
Status:
Recruiting
Last Changed:
Jan 18, 2022
First Changed:
Jan 13, 2022
Disease(s):
Oligodendroglioma
Intervention(s):
Radiation therapy
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma and H3 K27M-Mutant High-Grade Glioma
Status:
Not yet recruiting
Last Changed:
Dec 17, 2021
First Changed:
Oct 29, 2021
Disease(s):
Anaplastic Astrocytoma
Intervention(s):
Radiation TherapySelinexor
Study of Pembrolizumab and M032 (NSC 733972)
Status:
Not yet recruiting
Last Changed:
Dec 8, 2021
First Changed:
Oct 19, 2021
Disease(s):
Glioblastoma Multiforme
Intervention(s):
M032Pembrolizumab
Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma
Status:
Recruiting
Last Changed:
Dec 20, 2021
First Changed:
May 18, 2018
Disease(s):
Anaplastic Astrocytoma, IDH-Mutant
Intervention(s):
Questionnaire AdministrationRadiation TherapyTelaglenastat HydrochlorideTemozolomide
Multiple Doses of Neural Stem Cell Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
Status:
Not yet recruiting
Last Changed:
Feb 18, 2022
First Changed:
Dec 1, 2021
Disease(s):
Recurrent Anaplastic Astrocytoma
Intervention(s):
Neural Stem Cells-expressing CRAd-S-pk7Resection

Connect. Empower. Inspire.